跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Caberline - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Caberline
Approved
STANDARD
Caberline
Sun Pharmaceutical Industries Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
72440b1e65322b01
Company
Sun Pharmaceutical Industries Limited
Type
Standard
Approval Details
Approval Id
72440b1e65322b01
Drug Approval Philippines Name
Caberline
Product Name
Caberline
Registration Number
DR-XY48152
Brand Name
Caberline
Generic Name
Cabergoline
Dosage Form
Tablet
Dosage Strength
500 mcg
Manufacturer
Sun Pharmaceutical Industries Limited
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Issuance Date
26 September 2024
Expiry Date
01 July 2027
Pharmacologic Category
Prolactine Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
72440b1e65322b01
Type
Standard
Back to Philippines FDA Approvals